About jCyte
jCyte is a clinical-stage company focused on the application of progenitor cell-based technology in retinal diseases. The Company's allogeneic product candidate, jCell, is delivered by simple intravitreal injection without the need for surgery or immune suppression.
Founded in 2012 by Henry J. Klassen and Jing Yang.
- Founded
- 2012
- Employees
- 11 to 50
- Total funding
- $3.9M
- Headquarters
- Newport Beach
Leadership
The top of jCyte's org chart, with how many people report into each leader.
John Pollack
Chief Medical Officer
1 report
Victor Chao
VP, Chemistry, Manufacturing & Controls Operations
Henry J. Klassen
Founder
Rob Beathard
Chief Strategy Officer
Adrian Morris
Chief Development Officer
Joseph J. Ridolfi
Director Of Finance
Jing Yang
Co-Founder & Chief Scientific Officer
Angeline Lo
Senior Director Of Clinical Operations
Board
Baruch D. Kuppermann
Scientific Advisory Board
David S. Boyer
Scientific Advisory Board
Jeffrey Heier
Scientific Advisory Board
Peter K. Kaiser
Scientific Advisory Board
Jobs at jCyte
No open positions right now. Explore more companies on TheJobsMap.